OR WAIT null SECS
Florence Schleich, MD, PhD, a respiratory physician at the University of Liège in Belgium.
October 07, 2026
Video
Schleich says biologic switching in severe asthma should follow exacerbation phenotyping and discusses response predictors and standardized follow-up.
October 06, 2026
Article
Florence Schleich, MD, PhD, explains how exacerbation phenotypes and useful biomarkers shift across anti-IL-5, anti-IL-5R, and anti-TSLP therapies.